Хронічний ренокардіальний синдром: перспективи покращання якості медичної допомоги

200. Kunz R. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the rennin-angiotensin system on proteinuria in renal disease / R. Kunz, C. Friedrich, M. Wolbers, J. F. E. Mann // Ann. Intern. Med. - 2008. - Vol. 148. - P. 30-48.

201. Levey A. S. Cardiovascular disease in chronic renal disease / A. S. Levey, G. Eknoyan // Nephrol. Dial. Transplant. - 1999. - Vol. 14. - P. 828-833.

202. Levey A. S. Controling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? / A. S. Levey, J. A. Beto, B. E. Coronado [et al.] // Am. J. Kidney Dis. - 1998. - Vol. 32. - P. 853-906.

203. Levin A. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention / A. Levin, J. Singer, C. R. Thompson et al. // Am. J. Kidney Ms. - 1996. - Vol. 27. - P. 347-354.

204. Levin N. W. Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improve Global Outcomes Controversies Conference / N. W. Levin, P. Kotanko, K. U. Eckardt [et al.] // Kidney Int. - 2010. - P. 273-284.

205. Lewis E. J. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes / E. J. Lewis, L. G. Hunsicker, W. R. Clarke [et al.] // New Eng. J. Med. - 2001. - № 145. - P. 851-860.

206. Liang K. V. Acute decompensated heart failure and the cardiorenal syndrome / K. V. Liang, A. W. Williams, E. L. Greene / Crit. Care Med. - 2008. - Vol. 36. - P. S75-S88.

207. Lim S. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need? / S. Lim // Acta Med. Indones. - 2008. - Vol. 40, № 1. - P. 34-37.

208. Ljungman S. Renal function in severe congestive heart failure during treatment wiih enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial) / S. Ljungman, J. Kjekshus, K. Swedberg // Am. J. Cardiol. - 1992. - Vol. 70. - P. 479-487.

209. Locattelli F. The importance of early detection of chronic kidney disease / F. Locattelli, L. Del Vecchio, P. Pozzoni // Nephrol. Dial. Transplant. - 2002. - Vol. 17, Suppl.11. - P. 2-7.

210. Luscher T. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study / T. Luscher, M. Pieper, M. Tendera // European Heart Journal. - 2009. - Vol. 30. - P. 1590-1597.

211. Luss H. Renal effects of ularitide in patients with decompensated heart failure / H. Luss, V. Mitrovic, P. M. Seferovic [et al.] // Am. Heart J. - 2008. - Vol. 155. - P. e1-e8.

212. MacIver D. H. Is remodeling the dominant compensatory mechanism in both chronic heart failure with preserved and reduced left ventricular ejection fraction? / D. H. MacIver // Basic Res. Cardiol. - 2010. - Vol. 105, № 2. - P. 227-234.

213. Maeder M. T. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure / M. T. Maeder, D. P. Holst, D. M. Kaye // J. Card. Fail. - 2008. - Vol. 10. - P. 824-830.

214. Mahadevan G. Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study / G. Mahadevan [et al.] // Eur. J. Heart Fail. - 2012. - Vol. 14, № 1. - P. 106-112.

215. Malbrajn M. L. Results from the International Conference of Ex ports on Intra-abdominal Hypertension and Abdominal Compartment Syndrome / M. L. Malbrajn, M. L. Cheatham Kirkpatrick, M. Sugrue // Care Med. - 2006. - Vol. 32. - P. 1722-1732.

216. Martinez-Martin F. J. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study / F. J. Martinez-Martin, M. Saiz-Satjes // Expert. Rev. Cardiovasc. Ther. - 2008. - Vol. 6 (10). - P. 1347-1355.

217. Marwick T. H. Diabetic heart disease / T. H. Marwick // Heart. - 2006. - Vol. 92. - P. 296-300.

218. Massie B. M. Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction / B. M. Massie, P. E. Carson, J. J. McMurray // New Engl. J. Med. - 2008. - Vol. 359. - P. 2456-2467.

219. Matchar D. B. Systemetic rewiew: comparative effectiveness of ACE inhibitors and angiotensin II receptor blockers tor treating essential hypertension / D. B. Matchar, D. C. McCrory, L. A. Orlando [et al.] // Ann. Intern. Med. - 2008. - Vol. 148. - P. 16-29.

220. Matsumoto Y. Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair / Y. Matsumoto, V. Adams, C. Walther // European Heart Journal. - 2009. - Vol. 30. - P. 346-355.

221. Mayosi B. M. Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy in families with hypertension / B. M. Mayosi, P. J. Avery, M. Farrall [et al.] // European Heart Journal. - 2008. - Vol. 29. - P. 525-530.

222. McAlister F. A. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials / F. A. McAlister [et al.] // Eur. Heart J. - 2012. - Vol. 33, № 4. - P. 505-514.

223. McAlister F. A. Renal in sufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study / F. A. McAlister, J. Ezekowtiz, M. Tonelli // Circulatio. - 2003. - Vol. 109. - P. 1004-1009.

224. McCullough P. A. Cardiorenal risk: an important clinical intersection / P. A. McCullough // Rev. Cardiovasc. Med. - 2002. - Vol. 3. - P. 71-76.

225. McCullough P. A. Cardiovascular disease in chronic kidney disease from cardiologist's perspective / P. A. McCullough // Curr. Opin. Nephrol. Hypertens. - 2004. - Vol. 13. - P. 591-600.

226. McCullough P. A. Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program / P. A. McCullough, A. Whaley-Connell, W. W. Brown [et al.] // Intern. Med. J. - 2010. - Jan 4.

227. McCullough P. A. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004 / P. A. McCullough, S. Li, C. T. Jurkovitz [et al.] // Am. J. Kidney Dis. - 2008. - Vol. 51. - P. S38-S45.

228. McCullough P. A. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality / P. A. McCullough, S. Li // Am. Heart J. - 2008. - Vol. 156. - P. 277-283.

229. McCullough P. A. Independent components of chronic kidney disease as a cardiovascular risk state / P. A. McCullough, C. T. Jurkovitz // Arch. Intern. Med. - 2007. - Vol. 167. - P. 1122-1129.

230. McCullough P. A. The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment / P. A. McCullough, N. E. Lepor // Rev. Cardiovasc. Med. - 2005. - Vol. 6. - P. 1-10.

231. McMurray J. J. V. ACE Inhibitors in Cardiovascular Disease - Unbeatable? / J. J. V. McMurray // New Engl. J. Med. - 2008. - Vol. 358. - P. 1615-1616.

232. Metra M. Treatment of heart failure in the elderly: never say it's too late / M. Metra, L. Cas, B. Massie // European Heart Journal. - 2009. - Vol. 30. - P. 391-393.

233. Metra M. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance / M. Metra, S. Nodari, G. Parrinello [et al.] // Eur. J. Heart Fail. - 2008. - Vol. 10. - P. 188-195.

234. Michelucci A. Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy / A. Michelucci, G. Ricciardi, F. Sofi [et al.] // J. Card. Fail. - 2007. - № 13 (3). - Р. 207-210.

235. Moran A. Cystatin C concentration as a predictor of systolic and diastolic heart failure. / A. Moran, R. Katz, N. L. Smith [et al.] // J. Card. Fail. - 2007. - № 14 (1). - Р. 19-26.

236. Motte S. Endothelin receptor antagonists / S. Motte, K. McEntee, R. Naeije // Pharmacol. Ther. - 2006. - Vol. 110. - P. 386-414.

237. Mullens W. Elevated mira-abdominal pressure in acute decompensated heart failure / W. Mullens, Z. Abrahams, H. N. Skouri // J. Am. Coll. Cardiol. - 2008. - Vol. 51. - P. 300-306.

238. Mullens W. Importance of venous congestion for worsening renal function in advanced decompensated heart failure / W. Mullens, Z. Abrahams, G. S. Francis // J. Am. Coll. Cardiol. - 2009. - Vol. 53. - P. 589-596.

239. Mullens W. Prompt reduction of intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in. refractory decompensate heart failure / W. Mullens, Z. Abrahams, G. S. Francis [et al.] // J. Card. Fail. - 2008. - Vol. 14. - P. 508-514.

240. Murray Esler. The sympathetic nervous system through the ages: from Thjmas Willis to resistant hypertension / Esler Murray // Experimental Physiology. - 2011. - Vol. 96. - P. 611-622.

241. Nachman R. Platelets, Petechiae, and Preservation of the Vascular Wall / R. Nachman, S. Rafii // New Engl J Med. - 2008. - Vol. 359. - Р. 1261-1270.

242. Nagueh S. F. Recommendations for Evaluation of Left Ventricular Diastolic Function by Echocardiography / S. F. Nagueh, C. P. Appleton, T. C. Gillebert [et al.] // Eur. J. Echocardiography. - 2009. - Vol. 10. - P. 165-193.

243. Nakbi A. Association entre les paramиtres du stress oxydatif et les marqueurs de l'inflammation selon la gravitй du syndrome coronaire aigu / A. Nakbi, N. Koubaa, K. B. Hamda // La Tunise Medicinale. - 2011. - Vol. 89. - P. 621-626.

244. Nickolas T. L. Biomarkers in acute and chronic kidney disease / T. L. Nickolas, J. Barasch, P. Devarajan // Curr. Opin. Nephrol. Hypertens. - 2008. - Vol. 17. - P. 127-132.

245. Nobria A. Cardiorenal interactions : insights from the ESCAPE trial / A. Nobria, V. Hosselblad, A. Stebbins [et al.] // J. Am. Coll. Cardiol. - 2008. - Vol. 51. - P. 1264-1268.

246. Nohrta A. Cardiorenal interactions: insights from the ESCAPE trial / A. Nohrta, V. Hasselblad, A. Stebbms et al. // J. Am. Coll. Cardiol. - 2008. - Vol. 51. - P. 1268-1274.

247. Norris K. The role of rennin-angiotensin-aldosterone system in chronic kidney disease / K. Norris, C. Vaughn // Expert. Rev. Cardiovasc. Ther. - 2003. - Vol. 1, Issue 1. - P. 51-63.

248. O'Connor C. M. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure / C. M. O'Connor, R. C. Starling, A. F. Hernandez [et al.] / New Engl. J. Med. - 2011. - Vol. 365. - P. 32-43.

249. Owan Т. Е. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction / T. E. Owan, H. H. Chen, R. P. Frantz [et al.] // J. Card. Fail. - 2008. - Vol. 14. - P. 267-275.

250. Ozer J. S. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function / J. S. Ozer, F. Dieterle, S. Troth [et al.] / Nat. Biotechnol. - 2010. - Vol. 28, № 5. - P. 486-494.

251. Palevsky P. M. Epidemiology of acute renal failure: the tip of the iceberg / P. M. Palevsky // Clin. J. Am. Soc. Nephrol. - 2006. - № 1. - P. 6-7.

252. Pan J. P. The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure / J. P. Pan [et al.] // J. Chin. Med. Assoc. - 2004. - Vol. 67, № 5. - P. 222-228.

253. Panwar R. B. Atherothrombotic risk factors and premature coronary heart disease in India: a case-control study / R. B. Panwar, R. Gupta, B. K. Gupta // Indian J. Med. Res. - 2011. - Vol. 134, № 1. - P. 26-32.

254. Parikh C. R. New biomarkers of acute kidney injury / C. R. Parikh, P. Devarajan // Crit. Care Med. - 2008. - Vol. 36 (Suppl. 4). - P. 159-165.

255. Patel A. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial / A. Patel, ADVANCE Collaborative Group, S. MacMahon [et al.] // Lancet. - 2007. - Vol. 370 (9590). - P. 829-840.

256. Patel U. D. Quality of care and outcomes among patients with heart failure and chronic kidney disease; A Get With the Guidelines - Heart Failure Program study / U. D. Patel, A. F. Hernandez, L. Liang [et al.] // Am. Heart J. - 2008. - Vol. 156. - P. 674-681.

257. Persu A. Renal denervation ultima ratio or standard in treatment-resistant hypertension / A. Persu, J. Renkin, L. Thijs, J. A. Staessen // Hypertension. - 2012. - Vol. 60 (3). - P. 596-606.

258. Petrella R. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management / R. Petrella, P. Michailidis // Clin. Ther. - 2011. - Vol. 33, № 9. - P. 1190-1203.

259. Phan T. T. The pathophysiology of diastolic heart failure / T. T. Phan, M. Frenneaux // Biol. Rep. - 2010. - Vol. 24, № 2. - P. 1-16.

260. Raizada V. Intracardiac and intrarenal renin-angiotensin systems : mechanisms of cardiovascular and renal effects / V. Raizada, B. Skipper, W. Luo [et al.] // J. Investig. Med. - 2007. - Vol. 55. - P. 341-359.

261. Reboldi G. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials / G. Reboldi, G. Gentile, F. Angeli, P. Verdecchia // Vasc. Health Risk Manag. - 2009. - Vol. 5 (1). - P. 411-427.

262. Reinglas J. Cardiorenal syndrome and heart failure / J. Reinglas, H. Haddad, R. A. Davies, L. Mielniczuk // Heart Failure. - March 2010. - Vol. 25, Issue 2. - P. 141-147.

263. Remuzzi G. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes / G. Remuzzi, A. Benigni, A. Remuzzi // The Journal of Clinical Investigation. - 2006. - Vol. 116, № 2. - Р. 288-296.

264. Remuzzi G. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study / G. Remuzzi, M. Macia, P. Ruggenenti // J. Am. Soc. Nephrol. - 2006. - Vol. 17 (4 Suppl. 2). - P. S90-S97.

265. Riediger N. D. Cardiovascular risk according to plasma apolipoprotein and lipid profiles in a Canadian First Nation / N. D. Riediger, S. G. Bruce, T. K. Young // Prev. Chronic Dis. - 2011. - Vol. 8, № 1. - P. 1-8.

266. Roghi A. Impact of acute renal failure following percutaneous coronary intervention on long-term mortality / A. Roghi, S. Savonitto, C. Cavallini [et al.] // J. Cardiovasc. Med. - 2008. - Vol. 9. - P. 375-381.

267. Ronco C. Biomarkers in cardio-renal syndromes (Rassegna) / C. Ronco, D. N. Cruz // Altri Contributi Ligand Assay. - 2009. - Vol. 14, № 4. - P. 340-349.

268. Ronco C. Cardiorenal syndrome / C. Ronco, M. Haapio, A. A. House [et al.] // J. Am. Coll. Cardiol. - 2008. - Vol. 52. - P. 1527-1539.

269. Ronco C. Cardiorenal Syndromes in Critical Care / C. Ronco, R. Bellomo, P. A. McCullough // Contrib. Nephrol. - Basel, Karge, 2010. - Vol. 165.

270. Ronco C. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong / C. Ronco, A. A. House, M. Haapio // Intensive Care Med. - 2009. - Vol. 34. - P. 957-962.

271. Ronco С. Саrdio-renal syndrome: report from the consensus conference of the Acute Dialysis Quality Initiative / C. Ronco, S. Anker, P. McCullough [et al.] // Eur. Heart J. - 2010. - Vol. 31. - P. 703-711.

272. Ruelland V. Diastolic dysfunction in the elderly / V. Ruelland // Soins. - 2011. - Vol. 756, Suppl. Cardiologie. - P. S11-S12.

273. Ruilope L. M. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence / L. M. Riulope, J. Segura // Clin. Ther. - 2003. - Vol. 25, № 12. - P. 3044-3064.

274. Sahn D. J. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurement / D. J. Sahn, A. DeMaria, J. Kisslo, A. Weyman // Circulation. - 1978. - Vol. 58 (6). - P. 1072-1083.

275. Santoso A. Validity plasma B-type natriuretic peptide (BNP) for diastolic heart failure in Bali / A. Santoso, M. Yolanda, M. Donosepoetro // Heart, Lung and Circulation. - 2008. - № 17 (Suppl. 1). - Р. 39-40.

276. Sarnak M. J. Kidney disease as a risk factor for development of cardiovascular disease : a statement from the American Heart Councils in kidney and cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention / M. J. Sarnak, A. S. Levey, A. C. Schoolwerth [et al.] // Circulation. - 2003. - Vol. 108. - P. 2154-2169.

277. Sciacqua A. Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients / A. Sciacqua, M. Perticone, S. Miceli [et al.] // Nutr. Metab. Cardiovasc. Dis. - 2010. - Mar. 11.

278. Sciarretta S. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction / S. Sciarretta [et al.] // Clin. Sci (Lond). - 2009. - Vol. 116, № 6. - P. 467-477.

279. Schiffrin E. L. Chronic kidney disease. Effects on the cardiovascular system / E. L. Schiffrin, M. L. Lipman, J. F. E. Mann // Circulation. - 2007. - Vol. 116. - P. 85-97.

280. Schiller N. B. Recommendations for quantitation of the left ventricle by two-demensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms / N. B. Schiller, P. M. Shah, M. Crawford [et al.] // J. Am. Soc. Echocardiogr. - 1989. - Vol. 2 (5). - P. 358-367.

281. Schmidt A. Diagnostics and therapy of diastolic heart failure / A. Schmidt, B. Pieske // MMW Fortschr. Med. - 2009. - Vol. 151, № 15. - P. 27-30.

282. Schunkert H. Elevated C-Reactive Protein in Atherosclerosis - Chicken or Egg? / H. Schunkert, N. J. Samani // New Engl. J. Med. - 2008. - Vol. 359. - P. 1953-1955.

283. Seixas-Cambгo M. Pathophysiology of chronic heart failure / M. Seixas-Cambгo, A. F. Leite-Moreira // Rev. Port. Cardiol. - 2009. - Vol. 28, № 4. - P. 439-471.

284. Shahin Y. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials / Y. Shahin [et al.] //Atherosclerosis. - 2011. - Vol. 216, № 1. - P. 7-16.

285. Shah R. V. The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis / R. V. Shah, A. S. Desai, M. M. Givertz // J. Card. Fail. - 2010. - Vol. 16, № 3. - P. 260-267.

286. Shammas R. L. Diastolic heart failure and left ventricular diastolic dysfunction: what we know, and what we don't know! / R. L. Shammas, N. U. Khan, R. Nekkanti, A. Movahed // Int. J. Cardiol. - 2007. - № 115 (3). - Р. 284-292.

287. Shrestha K. Prognostic value of plasma levels of high-sensitivity C-reactive protein in chronic systolic heart failure: importance of diastolic function / K. Shrestha, W. H. Tang, W. Tong [et al.] // J. Card. Fail. - 2007. - № 13 (6, Suppl. 2). - P. 104.

288. Simone de G. Morbid obesity and left ventricular geometry / G. de Simone // Hypertension. - 2007. - Vol. 49 (1). - P. 7-9.

289. Smart N. A. Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failure / N. A. Smart [et al.] // Cardiol. Res. Pract. - 2011. - Vol. 2011, Article ID 532620. - 6 p.

290. Soni S. Cardiorenal syndrome: biomarkers linking kidney damage with heart failure / S. Soni, Y. Fahuan, C. Ronco // Biomarkers Med. - 2009. - Vol. 3, № 5. - P. 549-560.

291. Stanley W. C. Myocardial substrate metabolism in the normal and failing heart / W. C. Stanley, F. A. Recchia, G. D. Lopaschuk // Physiol. Rev. - 2005. - Vol. 85. - P. 1093-1129.

292. Stoica A. L. Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and prognosis in patients with peripheral arterial disease / A. L. Stoica [et al.] // J. Vasc. Surg. - 2010. - Vol. 52, № 1. - P. 103-109.

293. Strandberg T. E. Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long - term follow - up in men / T. E. Strandberg, A. Y. Strandberg, V. V. Salomaa // European Heart Journal. - 2009. - Vol. 30. - P. 1720-1727.

294. Suzuki O. Effects of an angiotensin 2 receptor blocker plus diuretic combination drug in chronic heart failure complicated by hypertension / O. Suzuki, H. Ishii, S. Kobayashi // J. Int. Med. Res. - 2011. - Vol. 39, № 4. - P. 1420-1426.

295. Takahashi S. Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartane on uric acid metabolism / S. Takahashi, Y. Moriwaki, T. Yamamoto [et al.] // Ann. Rheum. Dis. - 2003. - Vol. 62. - P. 572-575.

296. Takimoto E. Role of oxidative stress in cardiac hypertrophy and remodeling / E. Takimoto, D. Kass // Hypertension. - 2007. - № 49. - P. 241-248.

297. Tang W. H. Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure / W. H. Tang [et al.] // Am. J. Cardiol. - 2008. - Vol. 101, № 3. - P. 370-373.

298. Tanner H. Cytokine activation and disease progression in patients with stable moderate chronic heart failure / H. Tanner, P. Mohacsi, G. A. Fuller-Bicer [et al.] // J. Heart Lung Transplant. - 2007. - № 26 (6). - Р. 622-629.

299. Taylor W. Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia / W. Taylor // Clin. Med. - 2002. - Vol. 80, № 2. - P. 77-78.

300. Tonelli M. Chronic kidney disease and mortality risk: a systemic review / M. Tonelli, N. Wiebe Culleton, A. House [et al.] // J. Am. Sac. Nephrol. - 2006. - Vol. 17. - P. 2034-2047.

301. Toto R. D. Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy / R. D. Toto, M. Tian, K. Fakouhi [et al.] // J. Clin. Hypertens. (Greenwich). - 2008. - Vol. 10. - P. 761-769.

302. Vaziri N. D. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency / N. D. Vaziri, M. Dicus, N. D. Ho // Kidney. - 2003. - Vol. 63. - P. 179-185.

303. Vaz Pйrez A. The relationship between tumor necrosis factor-б, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure / A. Vaz Pйrez [et al.] // Int. J. Cardiol. - 2010. - Vol. 141, № 1. - P. 39-43.

304. Wagner С. Renal Function and Cardiovascular Risk / C. Wagner, C. Cystain // Eur. Nephrology. - 2010. - Vol. 4. - P. 49-54.

305. Walt R. K. Effect of kidney transplantation on left ventricular systolic function and congestive heart failure in patients with end-stage renal disease / R. K. Walt, G. S. Wang, S. S. Gottlieb [et al.] // J. Am. Coll. Cardiol. - 2005. - Vol. 45. - P. 1051-1060.

306. Whaley-Connell A. T. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004 / A. T. Whaley-Connell, J. R. Sowers // Am. J. Kidney Dis. - 2008. - Vol. 51. - P. S21-S29.

307. Williams E. S. C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study / E. S. Williams, S. J. Shah, S. Ali [et al.] // Eur. J. Heart Fail. - 2008. - № 10 (1). - Р. 63-69.

308. Winton F. R. The influence of venous pressure on the isolated mammalian kidney / F. R. Winton // J. Physiol. - 1931. - Vol. 72. - P. 49-61.

309. Wu C. K. Plasma levels of tumor necrosis factor-б and interleukin-6 are associated with diastolic heart failure through down regulation of sarcoplasmic reticulum Ca2+ ATPase / C. K. Wu [et al.] // Crit. Care Med. - 2011. - Vol. 39, № 5. - P. 984-992.

310. Zacho J. Genetically Elevated C - Reactive Protein and Ischemic Vascular Disease / J. Zacho, A. Tybjard-Hansen, J. S. Jensen, P. Grande // New Engl. J. Med. - 2008. - Vol. 359. - P. 1897-1908.

311. Zhang Q. L. Prevalence of chronic kidney disease in population-based studies: systematic review / Q. L. Zhang, D. Rothenbacher // BMC Public Health. - 2008. - Vol. 8. - P. 117.

312. Zucker I. H. Neurohumoral stimulation / I. H. Zucker, K. P. Patel, H. D. Schultz // Heart Fail. Clin. - 2012. - Vol. 8, № 1. - P. 87-99.

Размещено на Allbest.ru